Health
Sortilin may hold the key to combat pancreatic cancer more effectively. – Brinkwire
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in The American Journal of Pathology, scientists report the discovery of an increased level of the neuroprotein sortilin in pancreatic cancer cells that may open up the way to developing more effective treatment.
“There is currently no good therapy for pancreatic cancer,” explained lead investigator Hubert Hondermarck, Ph.D., School of Biomedical…
-
Business17 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News23 hours agoQueenslanders not out of the woods as more storms, heatwave conditions to continue after horror three days
-
Business17 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News17 hours agoDid AI write your accounting expert’s report? – Proctor